Oxford BioMedica

Oxford BioMedica
Medawar Centre
Robert Robinson Avenue

Latest Articles

Agreement to commercialise Trovax for cancer

Oxford BioMedica | Added: 28 Mar 2007

Oxford BioMedica and Sanofi-Aventis have entered into an exclusive global licensing agreement to de…

Oxford Biomedica to acquire Oxxon Therapeutics

Oxford BioMedica | Added: 12 Mar 2007

Acquisition of privately held biotechnology company, based in Oxford, UK, adds melanoma cancer vacc…

TroVax trial adopted by UK clinical trial network

Oxford BioMedica | Added: 10 Jan 2007

Oxford BioMedica reports that the Phase III Trist trial of its novel cancer immunotherapy, TroVax, …

Expanded licencing agreement for Lentivector

Oxford BioMedica | Added: 19 Dec 2006

Oxford BioMedica has expanded an existing licence agreement for its LentiVector technology with a m…

EU orphan drug designation for Trovax

Oxford BioMedica | Added: 8 Dec 2006

Oxford BioMedica's Trovax receives positive recommendation for orphan drug designation in renal can…



Free When You Join

Informative Newsletters & Tailored Alerts
Free Digital Journals
Unrestricted Access To Content & Downloads
Sign up now